PHAT vs GLIBK
Comparison between Phathom Pharmaceuticals Inc (PHAT, Company) and GCI Liberty Inc (GLIBK, Company).
PHAT is from the Healthcare sector, while GLIBK is from the Communication Services sector.
PHAT vs GLIBK - Performance Comparison
Key Characteristics
Financial metrics and valuation ratios
PHAT vs GLIBK - Historical Returns
Returns include dividend reinvestment.
PHAT vs GLIBK - Annual Returns (2019 - 2026)
Returns include dividend reinvestment.
| Year | PHAT | GLIBK |
|---|---|---|
| 2026 | -30.17% | -37.76% |
| 2025 | +126.33% | +20.03% |
| 2024 | -11.45% | N/A |
| 2023 | -23.85% | N/A |
| 2022 | -43.84% | N/A |
| 2021 | -41.91% | N/A |
| 2020 | +11.10% | N/A |
| 2019 | +26.59% | N/A |
PHAT vs GLIBK Drawdown Comparison
The maximum drawdown for PHAT was -95.81%, occurring on May 8, 2025. This drawdown has not yet recovered.
The maximum drawdown for GLIBK was -50.40%, occurring on Jun 25, 2026. This drawdown has not yet recovered.
The current PHAT drawdown is -79.91%. The current GLIBK drawdown is -43.86%.
| Rank | PHAT | GLIBK |
|---|---|---|
| #1 | -95.81% Jun 8, 2020 - May 8, 2025 | -50.40% Feb 20, 2026 - Jun 25, 2026 |
| #2 | -42.45% Feb 20, 2020 - May 7, 2020 | -21.92% Aug 22, 2025 - Jan 12, 2026 |
| #3 | -30.89% Nov 8, 2019 - Dec 23, 2019 | -13.17% Jul 21, 2025 - Aug 21, 2025 |
| #4 | -20.63% Dec 26, 2019 - Jan 27, 2020 | -6.93% Jan 13, 2026 - Feb 4, 2026 |
| #5 | -19.54% May 7, 2020 - May 27, 2020 | -5.51% Feb 10, 2026 - Feb 20, 2026 |
| #6 | -17.95% Jan 29, 2020 - Feb 19, 2020 | -0.77% Feb 4, 2026 - Feb 10, 2026 |
| #7 | -6.72% May 27, 2020 - Jun 2, 2020 | N/A |
| #8 | -5.69% Oct 25, 2019 - Nov 4, 2019 | N/A |
| #9 | -5.43% Dec 23, 2019 - Dec 26, 2019 | N/A |
| #10 | -3.56% Jun 2, 2020 - Jun 5, 2020 | N/A |
| #11 | -2.06% Nov 5, 2019 - Nov 7, 2019 | N/A |
| #12 | -0.05% Jan 27, 2020 - Jan 29, 2020 | N/A |
Correlation
Correlation between PHAT and GLIBK is 0.46 which considered as a weak positive correlation - the stocks show a slight tendency to move together.
Select Stocks to Compare
More Comparisons
Compare with similar stocks